Q5159 Injection, denosumab-dssb, 1 milligrams
Q-Codes
Also known as: denosumab biosimilar, RANKL inhibitor, bone-modifying therapy
Injection of denosumab-dssb (Rocakla), a biosimilar to denosumab, administered at 1 milligram per dose.
Clinical Context
Used for giant cell tumors of bone and osteoporosis prevention. Subcutaneous injection inhibiting receptor activator of RANKL protein.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.